We have gathered a team of specialists to achieve an ambitious plan of growing the company and strengthening the brand recognition to match the incredible potential of the flourishing demand.
We are a fully integrated European based medical cannabis company. Our strategic investments and partnerships will allow us to control every stage of the production path - from research, cultivation and processing to distribution. To focus on each integrated CBD stage, we’ve organized the corporate structure as of follows:
Farzad is a Physics graduate from the University of Manchester Institute of Science and Technology. He has 30 years experience working for large organizations such as JPMorgan, Goldman Sachs, Merrill Lynch, Credit Suisse and Barclays Capital specializing in derivatives pricing, risk management and regulatory reporting.
He spent 2.5 years at Otsuka pharmaceuticals Europe - A Japanese company focused on mental health advising them in Transparency, Compliance and regulatory reporting. Farzad is also a founder of Finity Asset, specializing in advising junior mining and oil & gas companies raise funding. Farzad has been responsible for the commercial development of Winchester MD (Formerly Green Biosciences).
Graduated with a major in Economics from McGill University (Montreal) Marti has over 2 years direct experience working in the UK Cannabis industry. Marti is the principal founder of Winchester MD (formerly Green Biosciences) and has been responsible for the successful growth of the brand HempElf – UK’s fastest growing CBD company. Marti has implemented streamlined operational controls that have kept costs at HempElf low while expanding the UK customer base from zero to 15,000 in just 12 months. He is now applying the same principles to grow HempElf in the rest of Europe.
Public Market & Business Development
Dan Kriznic has founded and co-founded a number of successful private and public companies in emerging markets with more recent involvement in Cannabis in Canada, US, Jamaica, Peru and Europe.Collectively he has been responsible for 9 public listings, $243 million in M&A transactions, $175 million in financings and $281 million in value for shareholders from selling companies. Dan founded High Standard after recognizing a need for financial and advisory services in fast growing emerging sectors.
He is the former CEO, Chairman and founder of Invictus MD Strategies (TSXV: GENE; OTC: IVITF) where he spearheaded over $62 million in acquisitions and raised over $115 million in financings. Dan now serves as advisor to the CEO and Chairman.
Dan co-founded Lithium X in 2015, as CFO and later as advisor to the chairman. Lithium X, a lithium exploration company, recently sold for $265 million in December 2017, representing a return to shareholders of 1,443%. He has been responsible for incubating companies in a variety of industries, including Cannabis, Technology, Education, Real Estate, Lithium and Healthcare. Through his strategic direction and execution, these companies have grown from nominal to over $1 billion in enterprise value. Dan began his career with 10 years at Deloitte, where he served in leadership roles in its Assurance and Advisory group, advising public and privately held companies. He is a Chartered Professional Accountant.
Ewan Phillips FCA
CHIEF FINANCIAL OFFICER
Ewan started his career at Deloitte focusing initially on audit and subsequently corporate finance. After leaving Deloitte he spent 17 years at Deltex Medical Group plc (LON:DEMG) – a health care company in the UK, where as CFO led the company to an IPO on the AIM gaining valuable exposure to raising capital, investor relations, corporate governance and scaling the business from 15 to over 100 employees and 20x sales growth. Ewan has completed over 50 finance transactions raising over £250 million and over 50 M&A transactions in aggregate excess value of £1 billion. He is a Chartered Accountant.
Fraser McGee is a UK qualified solicitor and specialised in corporate finance and investment fund work with prominent City law firms before moving to work in in-house with investment banks. After working as general counsel at the globally focused hedge fund RAB Capital plc with the Special Situations, Energy and Technology Funds Fraser became the CEO of an AIM quoted natural resources business, partnering with the Majors before setting up an independent consultancy business to provide general counsel services to the alternative investment sector.
That work extended to the European medical cannabis space from the early part of 2018 and included working with networks of entrepreneurs, professional service providers and investors in the industry around the world.
Fraser is also admitted as a solicitor of the Eastern Caribbean Supreme Court and has practised as an off-shore lawyer with a BVI and Cayman Islands law firm.
Natasha is a Chartered Professional Accountant with over 12 years of experience advising public and private companies in the areas of finance and accounting. She has experience with a variety of industries including blockchain technology, brand licensing, agriculture, franchising. As CFO of High Standard Capital Corp, Natasha is actively involved in assisting clients in obtaining a public listing, raising money, M&A transactions as well as ongoing regulatory compliance and financial reporting. Throughout her career, she has participated in M&A transactions with cumulative values in excess of $265MM and assisted with private placements in excess of $40MM.
Prior to joining High Standard, Natasha spent over six years in the assurance and advisory division at Deloitte, one of Canada’s leading professional services firms. In addition to this, Natasha has worked as the Director of Finance at Invictus MD Strategies Corp (TSXV: GENE –OTC: IVITF) and Senior Financial Manager at Mr. Lube Canada. Natasha holds a Bachelor’s degree in Accounting from British Columbia Institute of Technology and received her CPA designation in 2010.
VP of Product & Brand Development
An award winning, multi-talented creative director with extensive experience in brand development, product advertising and design. He is a passionate and inventive creator of innovative marketing strategies and campaigns. Seann brings a fresh and unique style to his campaigns and has been acknowledged for this through multiple industry awards.
VivoGreenare a leading expert in high tech cultivation practices including hydroponics, fogponics, aeroponics and indoor GMP cultivation plants. Using advanced cultivation methods such as Out Soil, they have made it possible to achieve enormous quantitative and qualitative increases in production and increase cultivation density to achieve higher yields.
By optimizing the use of labour, fertilizer, water, waste and crop cycles Vivo Green has created processes that reduce energy consumption, avoid the use of pesticide and insectoids and pollution of groundwater while protecting from fungal and bacterial disease.
Vivo Green’s cultivation is absolutely organic.
International law firm Hill Dickinson are the leading medical cannabis law firm in the UK. The Corporate team has a strong ECM reputation and advised on the first medical cannabis investment by an AIM listed company in the UK (FastForward Innovations’ investment in Nuuvera Inc. in 2017) and in March 2018 advised Sativa Investments PLC on the first IPO of a medical cannabis company in the UK since GW Pharma in 2001.
Hill Dickinson currently advise a number of leading UK, European and North American companies, private equity groups and institutions on medical cannabis law and regulation as well as licensing and corporate opportunities in Europe.
Hill Dickinson has an award winning Health and Life Sciences team, currently acting for more than 100 independent healthcare, pharmaceutical, life-science, artificial intelligence and biotech/biomedical companies as well as over 100 NHS bodies and regulators.
Hill Dickinson’s sector knowledge combined with its relationship with public health, life sciences and regulatory bodies un the UK, ensures the Firm provides a first-class and cost-effective solution on a wide range of legal transactions and matters affecting the medical cannabis industry.
The UHY Hacker Young Group is a network of independent accounting and consulting firms, which currently comprises over 100 partners and 540 professional staff providing a full range of services from our 23 offices across the UK. since GW Pharma in 2001. As an established brand we plan to capitalize in the timeliest manner while the market is still expanding aggressively and services are still in high demand. Currently, the market for CBD products is in extremely high demand and there are just a handful of suppliers who can manufacture the products we will be offering to our customers.
To Learn More, Reach out